trump glp 1 announcement drug price deal: Burning questions after Lilly, Novo agreement Trump's GLP-1 deals leaves questions

Description

Learn about the benefits and practical steps for transitioning patients from GLP-1 RAs to dual GLP-1/GIP receptor agonists, such as tirzepatide, to improve glycemic control in adults with type 2 diabetes.

From weight loss breakthroughsto type 2 diabetes management, and even anti-aging medicine, these treatments offer extraordinary promise.But with innovation comes risk

Starting in mid-2026, Medicare will begin covering these drugs for select patient groups and state Medicaid programs have the option to adopt similar coverage at these discounted rates

Discover Noom's program cost for 2026, covering Noom Weight and Noom Med, with detailed pricing, features, and free trial info

[Carb Blocker Metabolic Wellness & Energy Support] Berberine, EGCG, and Resveratrol support metabolic activity and energy utilization, helping you feel more balanced and work as appetite suppressant for weight loss